Literature DB >> 33495934

Sepsis-Associated Encephalopathy: from Pathophysiology to Progress in Experimental Studies.

Anderson Velasque Catarina1, Gisele Branchini2, Lais Bettoni2, Jarbas Rodrigues De Oliveira3, Fernanda Bordignon Nunes2,3.   

Abstract

Sepsis is an organ dysfunction caused by an uncontrolled inflammatory response from the host to an infection. Sepsis is the main cause of morbidity and mortality in intensive care units (ICU) worldwide. One of the first organs to suffer from injuries resulting from sepsis is the brain. The central nervous system (CNS) is particularly vulnerable to damage, mediated by inflammatory and oxidative processes, which can cause the sepsis-associated encephalopathy (SAE), being reported in up to 70% of septic patients. This review aims to bring a summary of the main pathophysiological changes and dysfunctions in SAE, and the main focuses of current experimental studies for new treatments and therapies. The pathophysiology of SAE is complex and multifactorial, combining intertwined processes, and is promoted by countless alterations and dysfunctions resulting from sepsis, such as inflammation, neuroinflammation, oxidative stress, reduced brain metabolism, and injuries to the integrity of the blood-brain barrier (BBB). The treatment is limited once its cause is not completely understood. The patient's sedation is far to provide an adequate treatment to this complex condition. Studies and experimental advances are important for a better understanding of its pathophysiology and for the development of new treatments, medicines, and therapies for the treatment of SAE and to reduce its effects during and after sepsis.

Entities:  

Keywords:  Brain; Encephalopathy; Experimental studies; Sepsis

Year:  2021        PMID: 33495934     DOI: 10.1007/s12035-021-02303-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  56 in total

Review 1.  Alterations in nitric oxide homeostasis during traumatic brain injury.

Authors:  Andrey V Kozlov; Soheyl Bahrami; Heinz Redl; Csaba Szabo
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-05       Impact factor: 5.187

2.  The Role of Secretase Pathway in Long-term Brain Inflammation and Cognitive Impairment in an Animal Model of Severe Sepsis.

Authors:  Cleonice Michelon; Monique Michels; Mariane Abatti; Andriele Vieira; Heloisa Borges; Diogo Dominguini; Tatiana Barichello; Felipe Dal-Pizzol
Journal:  Mol Neurobiol       Date:  2019-11-07       Impact factor: 5.590

3.  Long-term cerebral consequences of sepsis.

Authors:  Catherine N Widmann; Michael T Heneka
Journal:  Lancet Neurol       Date:  2014-06       Impact factor: 44.182

4.  Microglial Cells Depletion Increases Inflammation and Modifies Microglial Phenotypes in an Animal Model of Severe Sepsis.

Authors:  Monique Michels; Pricila Ávila; Bruna Pescador; Andriele Vieira; Mariane Abatti; Luana Cucker; Heloisa Borges; Amanda Indalécio Goulart; Celso Carvalho Junior; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol
Journal:  Mol Neurobiol       Date:  2019-04-24       Impact factor: 5.590

Review 5.  Sepsis-induced immune dysfunction: can immune therapies reduce mortality?

Authors:  Matthew J Delano; Peter A Ward
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

Review 6.  Sepsis-induced brain dysfunction.

Authors:  Nicolas Adam; Stanislas Kandelman; Jean Mantz; Fabrice Chrétien; Tarek Sharshar
Journal:  Expert Rev Anti Infect Ther       Date:  2013-02       Impact factor: 5.091

7.  Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations.

Authors:  Carolin Fleischmann; André Scherag; Neill K J Adhikari; Christiane S Hartog; Thomas Tsaganos; Peter Schlattmann; Derek C Angus; Konrad Reinhart
Journal:  Am J Respir Crit Care Med       Date:  2016-02-01       Impact factor: 21.405

8.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

Review 9.  Neuroanatomy and Physiology of Brain Dysfunction in Sepsis.

Authors:  Aurelien Mazeraud; Quentin Pascal; Franck Verdonk; Nicholas Heming; Fabrice Chrétien; Tarek Sharshar
Journal:  Clin Chest Med       Date:  2016-06       Impact factor: 2.878

Review 10.  Encephalopathy of infection and systemic inflammation.

Authors:  G Bryan Young
Journal:  J Clin Neurophysiol       Date:  2013-10       Impact factor: 2.177

View more
  11 in total

1.  Resolvin D1 protects against sepsis-associated encephalopathy in mice by inhibiting neuro-inflammation induced by microglia.

Authors:  Bing Xu; Mi Li; Tingting Cheng; Jun Xia; Xiaoming Deng; Jiong Hou
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 2.  Neuroimmune Regulation in Sepsis-Associated Encephalopathy: The Interaction Between the Brain and Peripheral Immunity.

Authors:  Yu-Xiao Liu; Yang Yu; Jing-Peng Liu; Wen-Jia Liu; Yang Cao; Run-Min Yan; Yong-Ming Yao
Journal:  Front Neurol       Date:  2022-06-27       Impact factor: 4.086

3.  Metformin Improves the Prognosis of Adult Mice with Sepsis-Associated Encephalopathy Better than That of Aged Mice.

Authors:  Gaofei Song; Huoyan Liang; Heng Song; Xianfei Ding; Dong Wang; Xiaojuan Zhang; Tongwen Sun
Journal:  J Immunol Res       Date:  2022-05-04       Impact factor: 4.493

4.  Emerging Trends and Hot Spots in Sepsis-Associated Encephalopathy Research From 2001 to 2021: A Bibliometric Analysis.

Authors:  Yizhe Zhang; Sifan Chen; Weitian Tian; Hui Zhu; Weiwei Li; Wanbing Dai; Xiao Zhang; Xiyao Gu; Diansan Su
Journal:  Front Med (Lausanne)       Date:  2022-02-28

5.  The Improvement of Sepsis-Associated Encephalopathy by P2X7R Inhibitor through Inhibiting the Omi/HtrA2 Apoptotic Signaling Pathway.

Authors:  Kaifang Wang; Meiyan Sun; Zhaodong Juan; Jianxin Zhang; Yingui Sun; Guizhi Wang; Chunling Wang; Yanjing Li; Wenwen Kong; Lulu Fan; Yue Zhang; Hongxiang Zhao; Xiaoyong Zhao
Journal:  Behav Neurol       Date:  2022-01-27       Impact factor: 3.342

Review 6.  Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments.

Authors:  Nobufumi Sekino; Magdy Selim; Amjad Shehadah
Journal:  J Neuroinflammation       Date:  2022-04-29       Impact factor: 9.587

Review 7.  Central role of microglia in sepsis-associated encephalopathy: From mechanism to therapy.

Authors:  Xiaoqian Yan; Kaiying Yang; Qi Xiao; Rongyao Hou; Xudong Pan; Xiaoyan Zhu
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

8.  Exploring the Muscle Metabolomics in the Mouse Model of Sepsis-Induced Acquired Weakness.

Authors:  Yikang Jiang; Qiang Wei; Wei Liu; Qiunan Chen; Xia Chen; Zhongzhen Yuan; Na Luo; Xi Chen; Chuanjiang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-16       Impact factor: 2.650

Review 9.  Sepsis-Induced Brain Dysfunction: Pathogenesis, Diagnosis, and Treatment.

Authors:  Shangwen Pan; Zheng Lv; Rui Wang; Huaqing Shu; Shiying Yuan; Yuan Yu; You Shang
Journal:  Oxid Med Cell Longev       Date:  2022-08-24       Impact factor: 7.310

10.  NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice.

Authors:  Lu Chen; Wenxiang Qing; Zexiong Yi; Guoxin Lin; Qianyi Peng; Fan Zhou
Journal:  Front Nutr       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.